Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Favennec, L.
Jave Ortiz, J.
Gargala, G.
Lopez Chegne, N.
Ayoub, A.
and
Rossignol, J. F.
2003.
Double‐blind, randomized, placebo‐controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru.
Alimentary Pharmacology & Therapeutics,
Vol. 17,
Issue. 2,
p.
265.
ALVAREZ, L. I.
MOTTIER, M. L.
and
LANUSSE, C. E.
2004.
Comparative assessment of the access of albendazole, fenbendazole and triclabendazole toFasciola hepatica: effect of bile in the incubation medium.
Parasitology,
Vol. 128,
Issue. 1,
p.
73.
Walker, S. M.
McKinstry, B.
Boray, J. C.
Brennan, G. P.
Trudgett, A.
Hoey, E. M.
Fletcher, H.
and
Fairweather, I.
2004.
Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.
Parasitology Research,
Vol. 94,
Issue. 6,
p.
427.
Wolstenholme, Adrian J.
Fairweather, Ian
Prichard, Roger
von Samson-Himmelstjerna, Georg
and
Sangster, Nicholas C.
2004.
Drug resistance in veterinary helminths.
Trends in Parasitology,
Vol. 20,
Issue. 10,
p.
469.
Meaney, M.
Haughey, S.
Brennan, G. P.
and
Fairweather, I.
2005.
Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica.
Parasitology Research,
Vol. 95,
Issue. 3,
p.
201.
Fairweather, I.
2005.
Triclabendazole: new skills to unravel an old(ish) enigma.
Journal of Helminthology,
Vol. 79,
Issue. 3,
p.
227.
Zhou, Hui
Tai, Yuanpo
Sun, Cuirong
and
Pan, Yuanjiang
2005.
Separation and characterization of synthetic impurities of triclabendazole by reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry.
Journal of Pharmaceutical and Biomedical Analysis,
Vol. 37,
Issue. 1,
p.
97.
Keiser, Jennifer
Engels, Dirk
Büscher, Gottfried
and
Utzinger, Jürg
2005.
Triclabendazole for the treatment of fascioliasis and paragonimiasis.
Expert Opinion on Investigational Drugs,
Vol. 14,
Issue. 12,
p.
1513.
ALVAREZ, L. I.
SOLANA, H. D.
MOTTIER, M. L.
VIRKEL, G. L.
FAIRWEATHER, I.
and
LANUSSE, C. E.
2005.
Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes.
Parasitology,
Vol. 131,
Issue. 04,
p.
501.
Meaney, M.
Allister, J.
McKinstry, B.
McLaughlin, K.
Brennan, G. P.
Forbes, A. B.
and
Fairweather, I.
2006.
Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke.
Parasitology Research,
Vol. 99,
Issue. 5,
p.
609.
Mottier, L.
Alvarez, L.
Fairweather, I.
and
Lanusse, C.
2006.
RESISTANCE-INDUCED CHANGES IN TRICLABENDAZOLE TRANSPORT IN FASCIOLA HEPATICA: IVERMECTIN REVERSAL EFFECT.
Journal of Parasitology,
Vol. 92,
Issue. 6,
p.
1355.
McKinstry, B.
Brennan, G. P.
Halferty, L.
Forbes, A. B.
and
Fairweather, I.
2007.
Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax).
Parasitology Research,
Vol. 101,
Issue. 4,
p.
929.
Vara-Del Río, M. P.
Villa, H.
Martinez-Valladares, M.
and
Rojo-Vázquez, F. A.
2007.
Genetic heterogeneity of Fasciola hepatica isolates in the northwest of Spain.
Parasitology Research,
Vol. 101,
Issue. 4,
p.
1003.
Meaney, M.
Allister, J.
McKinstry, B.
McLaughlin, K.
Brennan, G. P.
Forbes, A. B.
and
Fairweather, I.
2007.
Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.
Parasitology Research,
Vol. 100,
Issue. 5,
p.
1091.
Brennan, G.P.
Fairweather, I.
Trudgett, A.
Hoey, E.
McCoy
McConville, M.
Meaney, M.
Robinson, M.
McFerran, N.
Ryan, L.
Lanusse, C.
Mottier, L.
Alvarez, L.
Solana, H.
Virkel, G.
and
Brophy, P.M.
2007.
Understanding triclabendazole resistance.
Experimental and Molecular Pathology,
Vol. 82,
Issue. 2,
p.
104.
McConville, M.
Brennan, G. P.
McCoy, M.
Castillo, R.
Hernandez-Campos, A.
Ibarra, F.
and
Fairweather, I.
2007.
Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
Parasitology Research,
Vol. 100,
Issue. 2,
p.
365.
Hegazi, Ahmed G.
Abd El Hady, Faten K.
and
Shalaby, Hatem A.
2007.
An in vitro effect of propolis on adult worms of Fasciola gigantica.
Veterinary Parasitology,
Vol. 144,
Issue. 3-4,
p.
279.
McConville, M.
Brennan, G.P.
Flanagan, A.
Edgar, H.W.J.
McCoy, M.
Castillo, R.
Hernández-Campos, A.
and
Fairweather, I.
2008.
Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.
Veterinary Parasitology,
Vol. 153,
Issue. 1-2,
p.
52.
Ryan, Louise A.
Hoey, Elizabeth
Trudgett, Alan
Fairweather, Ian
Fuchs, Marc
Robinson, Mark W.
Chambers, Emma
Timson, David J.
Ryan, Eimear
Feltwell, Theresa
Ivens, Al
Bentley, Geoffrey
and
Johnston, David
2008.
Fasciola hepatica expresses multiple α- and β-tubulin isotypes.
Molecular and Biochemical Parasitology,
Vol. 159,
Issue. 1,
p.
73.
TONER, E.
BRENNAN, G. P.
WELLS, K.
McGEOWN, J. G.
and
FAIRWEATHER, I.
2008.
Physiological and morphological effects of genistein against the liver fluke,Fasciola hepatica.
Parasitology,
Vol. 135,
Issue. 10,
p.
1189.